Associations of cardiovascular diseases and type 2 diabetes with ophthalmic diseases in a population sample over 55 years old

Aim. To study associations of cardiovascular diseases and type 2 diabetes (T2D) with ophthalmic diseases in a population sample of men and women from middle to old age (Novosibirsk).

Material and methods. The population cohort was initially studied in 2003-2005 (n=9360, 45-69 years old, Novosibirsk, the Health, Alcohol and Psychosocial factors in Eastern Europe (HAPIEE) project). At the second survey (2015-2017) in a random subsample (n=1011), the following ophthalmic diseases were identified: hypertensive retinopathy (HR), diabetic retinopathy (DR), cataract, glaucoma, age-related macular degeneration (AMD), optic disc abnormalities, etc.

Results. The prevalence of HR signs in persons with and without hypertension (HTN) was 81 and 46%, respectively (p<0,001). This association persisted regardless of other factors (odds ratio, 2,27 (95% confidence interval: 1,78-4,17). The prevalence of AMD, cataract and DR increased in HTN, but associations were largely explained by metabolic factors in multivariate models. People with T2D more often than without T2D had signs of DR (9,3 vs 0,4%, p<0,001), AMD (22 vs 17%, p=0,042) and glaucoma (14 vs 7%, p=0,001). Associations of T2D with DR and glaucoma persisted regardless of other factors. Individuals with carotid atherosclerosis (CA) were 1,6 times more likely to have HR than those without CA when adjusted for sex, age, and smoking (p=0,013).

Conclusion. In the surveyed population sample of mainly elderly people, a number of associations between cardiometabolic and common ophthalmic diseases were revealed. The identified comorbidities may have important therapeutic and prophylactic applications in an aging population.

1. Abalmasova A. Statistical Study of the Average Life Expectancy of The Population in Russia. Journal “U”. Economy. Management. Finance. 2020;2:51-6. (In Russ.) https://www.portal-u.ru/index.php/journal/article/view/342 (8 февраля 2021).

2. Direev AO, Munts IV, Kuleshova ON, et al. Pathological changes of the eye retina at cardiovascular disease and diabetes mellitus. Ateroscleroz. 2020;16(2):49-62. (In Russ.) doi:10.15372/ATER20200205.

3. Hägg S, Thorn LM, Forsblom CM, et al. Different risk factor profiles for ischemic and hemorrhagic stroke in type 1 diabetes mellitus. Stroke. 2014;45(9):2558-62. doi:10.1161/STROKEAHA.114.005724.

4. Peasey A, Bobak M, Kubinova R, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC public health. 2006;6(1):1-10. doi:10.1186/1471-2458-6-255.

5. Avetisov SE, Egorov EA, Moshetova LA. Ophthalmology. National leadership. Moscow: Geotar-Media. 2019 p. 752. (In Russ.) ISBN: 978-5-9704-5125-0.

6. Rao VRRM, Natarajaboopathy R, Kumar KMS, et al. Hypertensive retinopathy-prevalence, risk factors and comorbids. J Evol Med Dent Sci. 2016;5(93):6872-5. doi:10.14260/jemds/2016/1553.

7. Malyutina SK, Mazdorova EV, Shapkina Myu, et al. The profile of drug treatment in subjects aged over 50 years with hypertension in an urban russian population. Kardiologiia. 2020;60(3):21-9. (In Russ.) doi:10.18087/cardio.2020.3.n948.

8. Kiseleva TN, Ezhov MV, Ajemyan NA. Violation of Retinal Circulation in Hypertension. Рharmathics. Farmateka. 2014;20:14-8. (In Russ.)

9. Wong TY, Mitchell P. Hypertensive retinopathy. New Engl J Med. 2004;351(22):2310-7. doi:10.1056/NEJMra032865.

10. Mehta R, Patil M, Page S. Comparative study of cataract in hypertensive patients and non-hypertensive patients. Indian J Clin Exp Ophthalmol. 2016;2(2):153. doi:10.5958/2395-1451.2016.00034.2.

11. Pearce I, Simó R, Lövestam‐Adrian M, et al. Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review. Diabetes Obes Metab. 2019;21(3):467-78. doi:10.1111/dom.13550.

12. Zhao YX, Chen XW. Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective cohort studies. Int J Ophthalmol. 2017;10(3):1430. doi:10.18240/ijo.2017.09.16.

13. Singh C, Jusufbegovic D, Lind J, et al. Glaucoma and Diabetes: A Sweet Connection. Proc IMPRS. 2020;3(1). doi:10.18060/24766.

14. Newman-Casey PA, Talwar N, Nan B, et al. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology. 2011;118(7):1318-26. doi:10.1016/j.ophtha.2010.11.022.

15. Topouzis F, Anastasopoulos E, Augood C, et al. Association of diabetes with age-related macular degeneration in the EUREYE study. Brit J Ophthalmol. 2009;93(8):1037-41. doi:10.1136/bjo.2008.146316.

16. He MS, Chang FL, Lin HZ, et al. The association between diabetes and age-related macular degeneration among the elderly in Taiwan. Diabetes Care. 2018;44(10):2202-11. doi:10.2337/dc18-0707.